Financial insights of PVLA

MyFinsight

For the quarter ending 2026-03-31.

Income Statement	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Research and development	9,334	5,178*	6,528	5,118
General and administrative	5,521	4,090*	3,649	4,132
Total operating expenses	14,855	9,267	10,177	9,250
Interest expense - convertible notes payable	-	0*	0	0
Operating loss	-14,855	-9,267*	-10,177	-9,250
Interest expense - royalty agreement	-2,039	-1,522*	-1,510	-1,354
Fair value adjustments on derivative liabilities - royalty agreement	-116	-94*	-82	-118
Fair value adjustments on convertible notes payable	-	0*	0	-
Fair value adjustments on derivative liabilities - contingent value right liability	202	-54*	-	-
Fair value adjustments on derivative liabilities - contingent value right agreement	-	-	-238	-
Other income - german r&d tax credit receivable	-	0*	-	-
Interest income, net	1,073	613*	628	690
Other income (expense), net	-32	-165*	34	561
Loss before income taxes	-15,767	-10,490*	-11,345	-9,471
Income tax benefit (expense)	0	0*	0	0
Net loss	-15,767	-10,490*	-11,345	-9,471
Less cumulative series d preferred dividends	-	-	0	0
Loss attributable to common stockholders	-	-	-11,345	-9,471
Unrealized gain on investments	4	-	-	-
Foreign currency translation loss (gain)	8	-80*	215	-108
Comprehensive loss	-15,755	-10,571	-11,130	-9,579

Basic EPS	-1.2	-0.908	-1.03	-0.86
Diluted EPS	-1.2	-0.908	-1.03	-0.86
Basic Average Shares	13,085,271	11,636,727	11,064,282	11,052,741
Diluted Average Shares	13,085,271	11,636,727	11,064,282	11,052,741

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.